Clinical Trials

NCT06242470 | RECRUITING | PHASE1
250 participants

A Study of MGC026 in Participants With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2024-03-06
Completion:
2028-05-31
Conditions
  • Advanced Solid Tumor
  • Advanced Cancer
  • Metastatic Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Non Small Cell Lung Cancer
  • Small-cell Lung Cancer
  • Bladder Cancer
  • Sarcoma
  • Endometrial Cancer
  • Melanoma
  • Castration Resistant Prostatic Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Gastro-esophageal Cancer
  • Pancreas Cancer
  • Clear Cell Renal Cell Carcinoma
  • Hepatocellular Carcinoma
  • Platinum-resistant Ovarian Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Esophageal Squamous Cell Cancer (SCC)
Interventions
  • BIOLOGICAL
No Results Yet
NCT06167486 | ACTIVE_NOT_RECRUITING | PHASE1
17 participants

SG2918 For Advanced Malignant Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-12-26
Completion:
2025-11-11
Conditions
  • Advanced Malignant Tumors
Interventions
  • DRUG
No Results Yet
NCT06159491 | RECRUITING | PHASE1/PHASE2
26 participants

Pacritinib in CMML

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2024-09-18
Completion:
2027-07-31
Conditions
  • Chronic Myelomonocytic Leukemia
Interventions
  • DRUG
No Results Yet
NCT06090552 | RECRUITING | NA
6000 participants

I CAN DO Surgical ACP

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2025-02-26
Completion:
2028-08-31
Conditions
  • Surgical Advanced Care Planning
Interventions
  • BEHAVIORAL
No Results Yet
NCT06058377 | RECRUITING | PHASE3
3680 participants

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-11-27
Completion:
2032-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page